Suggestions(5)
Exact(5)
Extension of the modeling framework to incorporate models for dose limiting toxicities (such as the hand foot syndrome) may be warranted to further investigate dosing strategies that may improve the benefit to risk ratio of this drug combination.
Together with predicting activity and potential adverse clinical signs, the inclusion of NHP testing bequeaths to efficacy models for dose titration and pharmacodynamic effects.
It is thus attractive to use physiologically based pharmacokinetic (PBPK) models for dose and species extrapolation.
It lists the six (of 32) models for dose response that had posterior probabilities (based on the BIC approximation) of > 1%, as well as those posterior probabilities.
Currently, uncertainty factors may be used to account for human variability, and "average" kinetic values are used in PBPK models for dose extrapolation.
Similar(55)
Bayesian decision procedures based on logistic regression models for dose-finding studies.
Because different studies have used different categories for fasting glucose, further and perhaps pooled analyses of data from large studies should be performed using flexible models for dose-response analysis to confirm our findings of a narrow range of fasting glucose levels with lowest mortality.
In other words, no data or information from warfarin-treated children was used to develop the model for dose prediction in children.
For consistency with the existing U.S. EPA RfD approach for MeHg, in this analysis I focus on the one-compartment model rather than the PBPK model for dose reconstruction.
Using the equation above, 2 different dose-effect models for E dose were explored.
Our models adjusted for dose to more closely approximate the risk estimates associated with standard-dose therapy.
Write better and faster with AI suggestions while staying true to your unique style.
Since I tried Ludwig back in 2017, I have been constantly using it in both editing and translation. Ever since, I suggest it to my translators at ProSciEditing.

Justyna Jupowicz-Kozak
CEO of Professional Science Editing for Scientists @ prosciediting.com